nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydralazine—hypertension—type 2 diabetes mellitus	0.388	1	CtDrD
Hydralazine—AOC3—type 2 diabetes mellitus	0.33	0.919	CbGaD
Hydralazine—CYP3A4—type 2 diabetes mellitus	0.0292	0.0813	CbGaD
Hydralazine—CYP3A4—Linagliptin—type 2 diabetes mellitus	0.0168	0.152	CbGbCtD
Hydralazine—CYP3A4—Sitagliptin—type 2 diabetes mellitus	0.015	0.136	CbGbCtD
Hydralazine—CYP3A4—Glipizide—type 2 diabetes mellitus	0.0137	0.124	CbGbCtD
Hydralazine—CYP3A4—Repaglinide—type 2 diabetes mellitus	0.012	0.109	CbGbCtD
Hydralazine—CYP3A4—Pioglitazone—type 2 diabetes mellitus	0.0108	0.0982	CbGbCtD
Hydralazine—CYP3A4—Nateglinide—type 2 diabetes mellitus	0.00821	0.0744	CbGbCtD
Hydralazine—CYP3A4—Orlistat—type 2 diabetes mellitus	0.00787	0.0713	CbGbCtD
Hydralazine—CYP3A4—Irbesartan—type 2 diabetes mellitus	0.00787	0.0713	CbGbCtD
Hydralazine—CYP3A4—Bromocriptine—type 2 diabetes mellitus	0.00744	0.0675	CbGbCtD
Hydralazine—AOC3—brown adipose tissue—type 2 diabetes mellitus	0.0065	0.235	CbGeAlD
Hydralazine—CYP3A4—Glyburide—type 2 diabetes mellitus	0.00554	0.0503	CbGbCtD
Hydralazine—CYP3A4—Losartan—type 2 diabetes mellitus	0.00507	0.046	CbGbCtD
Hydralazine—AOC3—peripheral nervous system—type 2 diabetes mellitus	0.00364	0.131	CbGeAlD
Hydralazine—AOC3—endothelium—type 2 diabetes mellitus	0.00242	0.0873	CbGeAlD
Hydralazine—RYR2—cardiovascular system—type 2 diabetes mellitus	0.00165	0.0596	CbGeAlD
Hydralazine—RYR2—SIDS Susceptibility Pathways—PHOX2A—type 2 diabetes mellitus	0.00147	0.0475	CbGpPWpGaD
Hydralazine—AOC3—retina—type 2 diabetes mellitus	0.00118	0.0424	CbGeAlD
Hydralazine—AOC3—nephron tubule—type 2 diabetes mellitus	0.00111	0.04	CbGeAlD
Hydralazine—P4HA1—islet of Langerhans—type 2 diabetes mellitus	0.0011	0.0397	CbGeAlD
Hydralazine—RYR2—Stimuli-sensing channels—TRPC1—type 2 diabetes mellitus	0.00106	0.0345	CbGpPWpGaD
Hydralazine—AOC3—cardiovascular system—type 2 diabetes mellitus	0.000995	0.0359	CbGeAlD
Hydralazine—AOC3—kidney—type 2 diabetes mellitus	0.000973	0.0351	CbGeAlD
Hydralazine—AOC3—pancreas—type 2 diabetes mellitus	0.000967	0.0349	CbGeAlD
Hydralazine—AOC3—cortex of kidney—type 2 diabetes mellitus	0.000948	0.0342	CbGeAlD
Hydralazine—RYR2—SIDS Susceptibility Pathways—NEUROD1—type 2 diabetes mellitus	0.000944	0.0306	CbGpPWpGaD
Hydralazine—P4HA1—nephron tubule—type 2 diabetes mellitus	0.000886	0.032	CbGeAlD
Hydralazine—AOC3—adipose tissue—type 2 diabetes mellitus	0.000877	0.0317	CbGeAlD
Hydralazine—P4HA1—cardiovascular system—type 2 diabetes mellitus	0.000795	0.0287	CbGeAlD
Hydralazine—P4HA1—pancreas—type 2 diabetes mellitus	0.000773	0.0279	CbGeAlD
Hydralazine—RYR2—SIDS Susceptibility Pathways—KCNQ1—type 2 diabetes mellitus	0.00077	0.0249	CbGpPWpGaD
Hydralazine—P4HA1—cortex of kidney—type 2 diabetes mellitus	0.000758	0.0273	CbGeAlD
Hydralazine—RYR2—SIDS Susceptibility Pathways—ECE1—type 2 diabetes mellitus	0.000716	0.0232	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—G6PC—type 2 diabetes mellitus	0.000716	0.0232	CbGpPWpGaD
Hydralazine—P4HA1—adipose tissue—type 2 diabetes mellitus	0.000701	0.0253	CbGeAlD
Hydralazine—RYR2—Ion channel transport—TRPC1—type 2 diabetes mellitus	0.000694	0.0225	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—PLN—type 2 diabetes mellitus	0.000679	0.022	CbGpPWpGaD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—ATP2A2—type 2 diabetes mellitus	0.000665	0.0216	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—GRK5—type 2 diabetes mellitus	0.000662	0.0214	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—GRK5—type 2 diabetes mellitus	0.000641	0.0208	CbGpPWpGaD
Hydralazine—RYR2—Ion channel transport—PLN—type 2 diabetes mellitus	0.000635	0.0206	CbGpPWpGaD
Hydralazine—AOC3—liver—type 2 diabetes mellitus	0.000615	0.0222	CbGeAlD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—ATP2A3—type 2 diabetes mellitus	0.000529	0.0171	CbGpPWpGaD
Hydralazine—RYR2—Stimuli-sensing channels—TRPC6—type 2 diabetes mellitus	0.000529	0.0171	CbGpPWpGaD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—TCF7L2—type 2 diabetes mellitus	0.000526	0.017	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—ATP2A3—type 2 diabetes mellitus	0.000512	0.0166	CbGpPWpGaD
Hydralazine—CYP3A4—Felbamate Metabolism—CYP2E1—type 2 diabetes mellitus	0.000501	0.0162	CbGpPWpGaD
Hydralazine—CYP3A4—Lidocaine metabolism—CYP1A2—type 2 diabetes mellitus	0.000495	0.016	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—ADRB3—type 2 diabetes mellitus	0.000495	0.016	CbGpPWpGaD
Hydralazine—RYR2—Ion channel transport—ATP2A3—type 2 diabetes mellitus	0.000495	0.016	CbGpPWpGaD
Hydralazine—P4HA1—liver—type 2 diabetes mellitus	0.000492	0.0177	CbGeAlD
Hydralazine—RYR2—Arrhythmogenic Right Ventricular Cardiomyopathy—GJA1—type 2 diabetes mellitus	0.000477	0.0155	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—CRHR1—type 2 diabetes mellitus	0.000463	0.015	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—ATF3—type 2 diabetes mellitus	0.000391	0.0127	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—ATP2A2—type 2 diabetes mellitus	0.00038	0.0123	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CPT1A—type 2 diabetes mellitus	0.000376	0.0122	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC26A9—type 2 diabetes mellitus	0.000375	0.0121	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—ATP2A2—type 2 diabetes mellitus	0.000368	0.0119	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—GCK—type 2 diabetes mellitus	0.000366	0.0119	CbGpPWpGaD
Hydralazine—RYR2—Ion channel transport—ATP2A2—type 2 diabetes mellitus	0.000355	0.0115	CbGpPWpGaD
Hydralazine—RYR2—Ion channel transport—TRPC6—type 2 diabetes mellitus	0.000345	0.0112	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—SNAP25—type 2 diabetes mellitus	0.000329	0.0106	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—CALCA—type 2 diabetes mellitus	0.000309	0.01	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—NOS1—type 2 diabetes mellitus	0.000294	0.00954	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—GJA1—type 2 diabetes mellitus	0.000272	0.00883	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—GJA1—type 2 diabetes mellitus	0.000264	0.00855	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—GJA1—type 2 diabetes mellitus	0.000263	0.00851	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—AR—type 2 diabetes mellitus	0.000261	0.00844	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—GNB3—type 2 diabetes mellitus	0.000255	0.00825	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC5A4—type 2 diabetes mellitus	0.00025	0.00811	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—GNB3—type 2 diabetes mellitus	0.000247	0.008	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—PPARGC1A—type 2 diabetes mellitus	0.000246	0.00796	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—GNB3—type 2 diabetes mellitus	0.000246	0.00796	CbGpPWpGaD
Hydralazine—CYP3A4—Codeine and Morphine Metabolism—ABCC2—type 2 diabetes mellitus	0.000243	0.00788	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—AVP—type 2 diabetes mellitus	0.000242	0.00785	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—G6PC—type 2 diabetes mellitus	0.000242	0.00783	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—TRPC1—type 2 diabetes mellitus	0.000242	0.00783	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—ADCY5—type 2 diabetes mellitus	0.000227	0.00736	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—PLN—type 2 diabetes mellitus	0.000221	0.00716	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—ADCY5—type 2 diabetes mellitus	0.00022	0.00713	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—NR3C1—type 2 diabetes mellitus	0.000211	0.00683	CbGpPWpGaD
Hydralazine—CYP3A4—kidney—type 2 diabetes mellitus	0.000206	0.00744	CbGeAlD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC30A8—type 2 diabetes mellitus	0.000197	0.00638	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—ABCC8—type 2 diabetes mellitus	0.000197	0.00638	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—CALM1—type 2 diabetes mellitus	0.000195	0.00632	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—HIF1A—type 2 diabetes mellitus	0.000192	0.00622	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—COX2—type 2 diabetes mellitus	0.00019	0.00614	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC5A2—type 2 diabetes mellitus	0.00019	0.00614	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—CALM1—type 2 diabetes mellitus	0.000189	0.00612	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—NCOA6—type 2 diabetes mellitus	0.000186	0.00604	CbGpPWpGaD
Hydralazine—RYR2—Calcium Regulation in the Cardiac Cell—PRKCB—type 2 diabetes mellitus	0.000183	0.00594	CbGpPWpGaD
Hydralazine—CYP3A4—Aflatoxin B1 metabolism—CYP1A2—type 2 diabetes mellitus	0.000182	0.00589	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—PRKCB—type 2 diabetes mellitus	0.000178	0.00575	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—ATP2A3—type 2 diabetes mellitus	0.000172	0.00558	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—HK1—type 2 diabetes mellitus	0.000161	0.00522	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—GCKR—type 2 diabetes mellitus	0.000156	0.00505	CbGpPWpGaD
Hydralazine—CYP3A4—Irinotecan Pathway—ABCC2—type 2 diabetes mellitus	0.000155	0.00503	CbGpPWpGaD
Hydralazine—CYP3A4—Liver X Receptor Pathway—SREBF1—type 2 diabetes mellitus	0.000151	0.0049	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—ABCC2—type 2 diabetes mellitus	0.000149	0.00484	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—NOS3—type 2 diabetes mellitus	0.000141	0.00457	CbGpPWpGaD
Hydralazine—CYP3A4—Aflatoxin B1 metabolism—GSTM1—type 2 diabetes mellitus	0.000139	0.00452	CbGpPWpGaD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—CYB5R4—type 2 diabetes mellitus	0.000135	0.00437	CbGpPWpGaD
Hydralazine—CYP3A4—Drug Induction of Bile Acid Pathway—ABCC2—type 2 diabetes mellitus	0.000133	0.00431	CbGpPWpGaD
Hydralazine—CYP3A4—liver—type 2 diabetes mellitus	0.00013	0.0047	CbGeAlD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC2A2—type 2 diabetes mellitus	0.00013	0.0042	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—GCK—type 2 diabetes mellitus	0.000124	0.00401	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—ATP2A2—type 2 diabetes mellitus	0.000124	0.00401	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC9A1—type 2 diabetes mellitus	0.000121	0.00391	CbGpPWpGaD
Hydralazine—CYP3A4—Tryptophan metabolism—AANAT—type 2 diabetes mellitus	0.00012	0.0039	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—TRPC6—type 2 diabetes mellitus	0.00012	0.00389	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—CETP—type 2 diabetes mellitus	0.000119	0.00387	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—CASP3—type 2 diabetes mellitus	0.000119	0.00386	CbGpPWpGaD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—NFKB1—type 2 diabetes mellitus	0.000112	0.00363	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—NFKB1—type 2 diabetes mellitus	0.000111	0.00361	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—PLAT—type 2 diabetes mellitus	0.000105	0.00341	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—VEGFA—type 2 diabetes mellitus	0.000101	0.00328	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC2A1—type 2 diabetes mellitus	0.0001	0.00325	CbGpPWpGaD
Hydralazine—CYP3A4—Constitutive Androstane Receptor Pathway—NCOA6—type 2 diabetes mellitus	0.0001	0.00324	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—SLC2A4—type 2 diabetes mellitus	9.62e-05	0.00312	CbGpPWpGaD
Hydralazine—CYP3A4—Fatty Acid Omega Oxidation—CYP2E1—type 2 diabetes mellitus	9.49e-05	0.00308	CbGpPWpGaD
Hydralazine—CYP3A4—Fatty Acid Omega Oxidation—CYP1A2—type 2 diabetes mellitus	9.38e-05	0.00304	CbGpPWpGaD
Hydralazine—RYR2—SIDS Susceptibility Pathways—TNF—type 2 diabetes mellitus	8.67e-05	0.00281	CbGpPWpGaD
Hydralazine—CYP3A4—Estrogen metabolism—CYP1A2—type 2 diabetes mellitus	8.54e-05	0.00277	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—GNB3—type 2 diabetes mellitus	8.29e-05	0.00269	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—HMOX1—type 2 diabetes mellitus	8.25e-05	0.00267	CbGpPWpGaD
Hydralazine—CYP3A4—Aflatoxin activation and detoxification—CYP1A2—type 2 diabetes mellitus	8.18e-05	0.00265	CbGpPWpGaD
Hydralazine—RYR2—Transmembrane transport of small molecules—AVP—type 2 diabetes mellitus	8.18e-05	0.00265	CbGpPWpGaD
Hydralazine—Neuropathy peripheral—Ramipril—type 2 diabetes mellitus	8.16e-05	0.000967	CcSEcCtD
Hydralazine—Thrombocytopenia—Gliclazide—type 2 diabetes mellitus	8.16e-05	0.000967	CcSEcCtD
Hydralazine—Tachycardia—Gliclazide—type 2 diabetes mellitus	8.13e-05	0.000964	CcSEcCtD
Hydralazine—Jaundice—Ramipril—type 2 diabetes mellitus	8.12e-05	0.000962	CcSEcCtD
Hydralazine—Conjunctivitis—Ramipril—type 2 diabetes mellitus	8.09e-05	0.000959	CcSEcCtD
Hydralazine—Flushing—Losartan—type 2 diabetes mellitus	8.09e-05	0.000959	CcSEcCtD
Hydralazine—Decreased appetite—Glyburide—type 2 diabetes mellitus	8.07e-05	0.000956	CcSEcCtD
Hydralazine—Urticaria—Bromocriptine—type 2 diabetes mellitus	8.07e-05	0.000956	CcSEcCtD
Hydralazine—Body temperature increased—Bromocriptine—type 2 diabetes mellitus	8.03e-05	0.000951	CcSEcCtD
Hydralazine—CYP3A4—Constitutive Androstane Receptor Pathway—ABCC2—type 2 diabetes mellitus	8.02e-05	0.0026	CbGpPWpGaD
Hydralazine—Gastrointestinal disorder—Glyburide—type 2 diabetes mellitus	8.01e-05	0.00095	CcSEcCtD
Hydralazine—Tremor—Metformin—type 2 diabetes mellitus	8.01e-05	0.000949	CcSEcCtD
Hydralazine—Myalgia—Valsartan—type 2 diabetes mellitus	7.99e-05	0.000947	CcSEcCtD
Hydralazine—Arthralgia—Valsartan—type 2 diabetes mellitus	7.99e-05	0.000947	CcSEcCtD
Hydralazine—Dizziness—Glipizide—type 2 diabetes mellitus	7.98e-05	0.000945	CcSEcCtD
Hydralazine—Pruritus—Glimepiride—type 2 diabetes mellitus	7.96e-05	0.000944	CcSEcCtD
Hydralazine—Anxiety—Valsartan—type 2 diabetes mellitus	7.96e-05	0.000944	CcSEcCtD
Hydralazine—CYP3A4—Xenobiotics—CYP2E1—type 2 diabetes mellitus	7.94e-05	0.00257	CbGpPWpGaD
Hydralazine—Ill-defined disorder—Metformin—type 2 diabetes mellitus	7.93e-05	0.00094	CcSEcCtD
Hydralazine—Diarrhoea—Pioglitazone—type 2 diabetes mellitus	7.91e-05	0.000937	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—APOB—type 2 diabetes mellitus	7.91e-05	0.00256	CbGpPWpGaD
Hydralazine—Myalgia—Orlistat—type 2 diabetes mellitus	7.89e-05	0.000936	CcSEcCtD
Hydralazine—Anxiety—Orlistat—type 2 diabetes mellitus	7.87e-05	0.000932	CcSEcCtD
Hydralazine—CYP3A4—Xenobiotics—CYP1A2—type 2 diabetes mellitus	7.85e-05	0.00254	CbGpPWpGaD
Hydralazine—Discomfort—Orlistat—type 2 diabetes mellitus	7.8e-05	0.000924	CcSEcCtD
Hydralazine—Hypotension—Gliclazide—type 2 diabetes mellitus	7.79e-05	0.000923	CcSEcCtD
Hydralazine—Agranulocytosis—Ramipril—type 2 diabetes mellitus	7.77e-05	0.000921	CcSEcCtD
Hydralazine—Muscle spasms—Irbesartan—type 2 diabetes mellitus	7.75e-05	0.000919	CcSEcCtD
Hydralazine—Malaise—Metformin—type 2 diabetes mellitus	7.71e-05	0.000913	CcSEcCtD
Hydralazine—Diarrhoea—Glimepiride—type 2 diabetes mellitus	7.7e-05	0.000913	CcSEcCtD
Hydralazine—Diarrhoea—Sitagliptin—type 2 diabetes mellitus	7.68e-05	0.00091	CcSEcCtD
Hydralazine—Vomiting—Glipizide—type 2 diabetes mellitus	7.67e-05	0.000909	CcSEcCtD
Hydralazine—Oedema—Valsartan—type 2 diabetes mellitus	7.66e-05	0.000908	CcSEcCtD
Hydralazine—Feeling abnormal—Glyburide—type 2 diabetes mellitus	7.65e-05	0.000907	CcSEcCtD
Hydralazine—Dizziness—Pioglitazone—type 2 diabetes mellitus	7.64e-05	0.000906	CcSEcCtD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCC2—type 2 diabetes mellitus	7.64e-05	0.00248	CbGpPWpGaD
Hydralazine—CYP3A4—Tamoxifen metabolism—CYP2E1—type 2 diabetes mellitus	7.64e-05	0.00247	CbGpPWpGaD
Hydralazine—Rash—Glipizide—type 2 diabetes mellitus	7.6e-05	0.000901	CcSEcCtD
Hydralazine—Dermatitis—Glipizide—type 2 diabetes mellitus	7.6e-05	0.000901	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Gliclazide—type 2 diabetes mellitus	7.59e-05	0.0009	CcSEcCtD
Hydralazine—Oedema—Orlistat—type 2 diabetes mellitus	7.57e-05	0.000897	CcSEcCtD
Hydralazine—Headache—Glipizide—type 2 diabetes mellitus	7.56e-05	0.000896	CcSEcCtD
Hydralazine—Tremor—Irbesartan—type 2 diabetes mellitus	7.55e-05	0.000895	CcSEcCtD
Hydralazine—Palpitations—Metformin—type 2 diabetes mellitus	7.55e-05	0.000895	CcSEcCtD
Hydralazine—CYP3A4—Tamoxifen metabolism—CYP1A2—type 2 diabetes mellitus	7.55e-05	0.00245	CbGpPWpGaD
Hydralazine—Thrombocytopenia—Valsartan—type 2 diabetes mellitus	7.5e-05	0.000889	CcSEcCtD
Hydralazine—Paraesthesia—Gliclazide—type 2 diabetes mellitus	7.48e-05	0.000887	CcSEcCtD
Hydralazine—Ill-defined disorder—Irbesartan—type 2 diabetes mellitus	7.48e-05	0.000887	CcSEcCtD
Hydralazine—Hepatitis—Ramipril—type 2 diabetes mellitus	7.47e-05	0.000886	CcSEcCtD
Hydralazine—Anaemia—Irbesartan—type 2 diabetes mellitus	7.45e-05	0.000883	CcSEcCtD
Hydralazine—Dizziness—Glimepiride—type 2 diabetes mellitus	7.44e-05	0.000882	CcSEcCtD
Hydralazine—Dyspnoea—Gliclazide—type 2 diabetes mellitus	7.43e-05	0.000881	CcSEcCtD
Hydralazine—Dizziness—Sitagliptin—type 2 diabetes mellitus	7.42e-05	0.000879	CcSEcCtD
Hydralazine—Agitation—Irbesartan—type 2 diabetes mellitus	7.41e-05	0.000878	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—ADCY5—type 2 diabetes mellitus	7.39e-05	0.00239	CbGpPWpGaD
Hydralazine—Urticaria—Glyburide—type 2 diabetes mellitus	7.37e-05	0.000874	CcSEcCtD
Hydralazine—Dyspepsia—Gliclazide—type 2 diabetes mellitus	7.34e-05	0.00087	CcSEcCtD
Hydralazine—Anorexia—Valsartan—type 2 diabetes mellitus	7.3e-05	0.000865	CcSEcCtD
Hydralazine—Muscle spasms—Losartan—type 2 diabetes mellitus	7.3e-05	0.000865	CcSEcCtD
Hydralazine—Myalgia—Metformin—type 2 diabetes mellitus	7.27e-05	0.000862	CcSEcCtD
Hydralazine—Malaise—Irbesartan—type 2 diabetes mellitus	7.27e-05	0.000862	CcSEcCtD
Hydralazine—Headache—Pioglitazone—type 2 diabetes mellitus	7.24e-05	0.000858	CcSEcCtD
Hydralazine—Leukopenia—Irbesartan—type 2 diabetes mellitus	7.22e-05	0.000856	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Gliclazide—type 2 diabetes mellitus	7.2e-05	0.000853	CcSEcCtD
Hydralazine—Discomfort—Metformin—type 2 diabetes mellitus	7.19e-05	0.000852	CcSEcCtD
Hydralazine—Nausea—Glipizide—type 2 diabetes mellitus	7.16e-05	0.000849	CcSEcCtD
Hydralazine—Vomiting—Glimepiride—type 2 diabetes mellitus	7.16e-05	0.000848	CcSEcCtD
Hydralazine—Hypotension—Valsartan—type 2 diabetes mellitus	7.16e-05	0.000848	CcSEcCtD
Hydralazine—Vomiting—Sitagliptin—type 2 diabetes mellitus	7.13e-05	0.000846	CcSEcCtD
Hydralazine—Constipation—Gliclazide—type 2 diabetes mellitus	7.13e-05	0.000845	CcSEcCtD
Hydralazine—Tremor—Losartan—type 2 diabetes mellitus	7.11e-05	0.000843	CcSEcCtD
Hydralazine—Rash—Glimepiride—type 2 diabetes mellitus	7.1e-05	0.000841	CcSEcCtD
Hydralazine—Dermatitis—Glimepiride—type 2 diabetes mellitus	7.09e-05	0.00084	CcSEcCtD
Hydralazine—Rash—Sitagliptin—type 2 diabetes mellitus	7.07e-05	0.000839	CcSEcCtD
Hydralazine—Dermatitis—Sitagliptin—type 2 diabetes mellitus	7.07e-05	0.000838	CcSEcCtD
Hydralazine—Headache—Glimepiride—type 2 diabetes mellitus	7.05e-05	0.000836	CcSEcCtD
Hydralazine—Ill-defined disorder—Losartan—type 2 diabetes mellitus	7.04e-05	0.000835	CcSEcCtD
Hydralazine—RYR2—Myometrial Relaxation and Contraction Pathways—IL6—type 2 diabetes mellitus	7.03e-05	0.00228	CbGpPWpGaD
Hydralazine—Headache—Sitagliptin—type 2 diabetes mellitus	7.03e-05	0.000833	CcSEcCtD
Hydralazine—Anaemia—Losartan—type 2 diabetes mellitus	7.01e-05	0.000831	CcSEcCtD
Hydralazine—RYR2—SIDS Susceptibility Pathways—IL6—type 2 diabetes mellitus	6.99e-05	0.00227	CbGpPWpGaD
Hydralazine—Musculoskeletal discomfort—Valsartan—type 2 diabetes mellitus	6.98e-05	0.000827	CcSEcCtD
Hydralazine—Agitation—Losartan—type 2 diabetes mellitus	6.97e-05	0.000827	CcSEcCtD
Hydralazine—Oedema—Metformin—type 2 diabetes mellitus	6.97e-05	0.000827	CcSEcCtD
Hydralazine—Diarrhoea—Bromocriptine—type 2 diabetes mellitus	6.95e-05	0.000824	CcSEcCtD
Hydralazine—Flushing—Ramipril—type 2 diabetes mellitus	6.94e-05	0.000822	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Orlistat—type 2 diabetes mellitus	6.89e-05	0.000817	CcSEcCtD
Hydralazine—Paraesthesia—Valsartan—type 2 diabetes mellitus	6.88e-05	0.000815	CcSEcCtD
Hydralazine—Feeling abnormal—Gliclazide—type 2 diabetes mellitus	6.87e-05	0.000814	CcSEcCtD
Hydralazine—Arthralgia—Irbesartan—type 2 diabetes mellitus	6.87e-05	0.000814	CcSEcCtD
Hydralazine—Myalgia—Irbesartan—type 2 diabetes mellitus	6.87e-05	0.000814	CcSEcCtD
Hydralazine—Malaise—Losartan—type 2 diabetes mellitus	6.84e-05	0.000811	CcSEcCtD
Hydralazine—Anxiety—Irbesartan—type 2 diabetes mellitus	6.84e-05	0.000811	CcSEcCtD
Hydralazine—Hypersensitivity—Glyburide—type 2 diabetes mellitus	6.84e-05	0.000811	CcSEcCtD
Hydralazine—Thrombocytopenia—Metformin—type 2 diabetes mellitus	6.83e-05	0.000809	CcSEcCtD
Hydralazine—Dyspnoea—Valsartan—type 2 diabetes mellitus	6.83e-05	0.000809	CcSEcCtD
Hydralazine—Paraesthesia—Orlistat—type 2 diabetes mellitus	6.79e-05	0.000805	CcSEcCtD
Hydralazine—Leukopenia—Losartan—type 2 diabetes mellitus	6.79e-05	0.000805	CcSEcCtD
Hydralazine—Discomfort—Irbesartan—type 2 diabetes mellitus	6.78e-05	0.000804	CcSEcCtD
Hydralazine—CYP3A4—Farnesoid X Receptor  Pathway—PPARGC1A—type 2 diabetes mellitus	6.76e-05	0.00219	CbGpPWpGaD
Hydralazine—Dyspepsia—Valsartan—type 2 diabetes mellitus	6.74e-05	0.000799	CcSEcCtD
Hydralazine—Dizziness—Bromocriptine—type 2 diabetes mellitus	6.71e-05	0.000796	CcSEcCtD
Hydralazine—Palpitations—Losartan—type 2 diabetes mellitus	6.71e-05	0.000795	CcSEcCtD
Hydralazine—Nausea—Glimepiride—type 2 diabetes mellitus	6.69e-05	0.000792	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—PPARA—type 2 diabetes mellitus	6.67e-05	0.00216	CbGpPWpGaD
Hydralazine—Nausea—Sitagliptin—type 2 diabetes mellitus	6.66e-05	0.00079	CcSEcCtD
Hydralazine—Dyspepsia—Orlistat—type 2 diabetes mellitus	6.66e-05	0.00079	CcSEcCtD
Hydralazine—Decreased appetite—Valsartan—type 2 diabetes mellitus	6.66e-05	0.000789	CcSEcCtD
Hydralazine—Anorexia—Metformin—type 2 diabetes mellitus	6.65e-05	0.000788	CcSEcCtD
Hydralazine—Urticaria—Gliclazide—type 2 diabetes mellitus	6.62e-05	0.000785	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Valsartan—type 2 diabetes mellitus	6.61e-05	0.000784	CcSEcCtD
Hydralazine—Body temperature increased—Gliclazide—type 2 diabetes mellitus	6.59e-05	0.000781	CcSEcCtD
Hydralazine—Oedema—Irbesartan—type 2 diabetes mellitus	6.58e-05	0.00078	CcSEcCtD
Hydralazine—Decreased appetite—Orlistat—type 2 diabetes mellitus	6.58e-05	0.00078	CcSEcCtD
Hydralazine—Pruritus—Glyburide—type 2 diabetes mellitus	6.57e-05	0.000778	CcSEcCtD
Hydralazine—Constipation—Valsartan—type 2 diabetes mellitus	6.55e-05	0.000776	CcSEcCtD
Hydralazine—CYP3A4—Estrogen metabolism—GSTM1—type 2 diabetes mellitus	6.55e-05	0.00212	CbGpPWpGaD
Hydralazine—Gastrointestinal disorder—Orlistat—type 2 diabetes mellitus	6.53e-05	0.000774	CcSEcCtD
Hydralazine—Hypotension—Metformin—type 2 diabetes mellitus	6.52e-05	0.000772	CcSEcCtD
Hydralazine—Arthralgia—Losartan—type 2 diabetes mellitus	6.46e-05	0.000766	CcSEcCtD
Hydralazine—Myalgia—Losartan—type 2 diabetes mellitus	6.46e-05	0.000766	CcSEcCtD
Hydralazine—Vomiting—Bromocriptine—type 2 diabetes mellitus	6.46e-05	0.000765	CcSEcCtD
Hydralazine—Thrombocytopenia—Irbesartan—type 2 diabetes mellitus	6.44e-05	0.000764	CcSEcCtD
Hydralazine—Anxiety—Losartan—type 2 diabetes mellitus	6.44e-05	0.000763	CcSEcCtD
Hydralazine—Tachycardia—Irbesartan—type 2 diabetes mellitus	6.42e-05	0.000761	CcSEcCtD
Hydralazine—Rash—Bromocriptine—type 2 diabetes mellitus	6.4e-05	0.000759	CcSEcCtD
Hydralazine—Dermatitis—Bromocriptine—type 2 diabetes mellitus	6.4e-05	0.000758	CcSEcCtD
Hydralazine—Discomfort—Losartan—type 2 diabetes mellitus	6.38e-05	0.000757	CcSEcCtD
Hydralazine—Headache—Bromocriptine—type 2 diabetes mellitus	6.36e-05	0.000754	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Metformin—type 2 diabetes mellitus	6.35e-05	0.000753	CcSEcCtD
Hydralazine—Diarrhoea—Glyburide—type 2 diabetes mellitus	6.35e-05	0.000753	CcSEcCtD
Hydralazine—Anorexia—Irbesartan—type 2 diabetes mellitus	6.27e-05	0.000744	CcSEcCtD
Hydralazine—Paraesthesia—Metformin—type 2 diabetes mellitus	6.26e-05	0.000742	CcSEcCtD
Hydralazine—Muscle spasms—Ramipril—type 2 diabetes mellitus	6.26e-05	0.000742	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—APOA1—type 2 diabetes mellitus	6.25e-05	0.00203	CbGpPWpGaD
Hydralazine—Feeling abnormal—Orlistat—type 2 diabetes mellitus	6.24e-05	0.000739	CcSEcCtD
Hydralazine—Dyspnoea—Metformin—type 2 diabetes mellitus	6.22e-05	0.000737	CcSEcCtD
Hydralazine—Oedema—Losartan—type 2 diabetes mellitus	6.19e-05	0.000734	CcSEcCtD
Hydralazine—Hypotension—Irbesartan—type 2 diabetes mellitus	6.15e-05	0.000729	CcSEcCtD
Hydralazine—Hypersensitivity—Gliclazide—type 2 diabetes mellitus	6.14e-05	0.000728	CcSEcCtD
Hydralazine—Dyspepsia—Metformin—type 2 diabetes mellitus	6.14e-05	0.000728	CcSEcCtD
Hydralazine—Tremor—Ramipril—type 2 diabetes mellitus	6.1e-05	0.000723	CcSEcCtD
Hydralazine—Urticaria—Valsartan—type 2 diabetes mellitus	6.08e-05	0.000721	CcSEcCtD
Hydralazine—Thrombocytopenia—Losartan—type 2 diabetes mellitus	6.06e-05	0.000719	CcSEcCtD
Hydralazine—Decreased appetite—Metformin—type 2 diabetes mellitus	6.06e-05	0.000719	CcSEcCtD
Hydralazine—Tachycardia—Losartan—type 2 diabetes mellitus	6.04e-05	0.000716	CcSEcCtD
Hydralazine—Ill-defined disorder—Ramipril—type 2 diabetes mellitus	6.04e-05	0.000716	CcSEcCtD
Hydralazine—Nausea—Bromocriptine—type 2 diabetes mellitus	6.03e-05	0.000715	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Metformin—type 2 diabetes mellitus	6.02e-05	0.000714	CcSEcCtD
Hydralazine—Urticaria—Orlistat—type 2 diabetes mellitus	6.01e-05	0.000713	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Irbesartan—type 2 diabetes mellitus	6e-05	0.000711	CcSEcCtD
Hydralazine—Body temperature increased—Orlistat—type 2 diabetes mellitus	5.98e-05	0.000709	CcSEcCtD
Hydralazine—Agitation—Ramipril—type 2 diabetes mellitus	5.98e-05	0.000709	CcSEcCtD
Hydralazine—Constipation—Metformin—type 2 diabetes mellitus	5.96e-05	0.000707	CcSEcCtD
Hydralazine—Paraesthesia—Irbesartan—type 2 diabetes mellitus	5.91e-05	0.0007	CcSEcCtD
Hydralazine—Anorexia—Losartan—type 2 diabetes mellitus	5.9e-05	0.0007	CcSEcCtD
Hydralazine—Vomiting—Glyburide—type 2 diabetes mellitus	5.9e-05	0.0007	CcSEcCtD
Hydralazine—Pruritus—Gliclazide—type 2 diabetes mellitus	5.9e-05	0.000699	CcSEcCtD
Hydralazine—Malaise—Ramipril—type 2 diabetes mellitus	5.87e-05	0.000696	CcSEcCtD
Hydralazine—Dyspnoea—Irbesartan—type 2 diabetes mellitus	5.87e-05	0.000695	CcSEcCtD
Hydralazine—Rash—Glyburide—type 2 diabetes mellitus	5.85e-05	0.000694	CcSEcCtD
Hydralazine—Dermatitis—Glyburide—type 2 diabetes mellitus	5.85e-05	0.000693	CcSEcCtD
Hydralazine—Leukopenia—Ramipril—type 2 diabetes mellitus	5.82e-05	0.00069	CcSEcCtD
Hydralazine—Headache—Glyburide—type 2 diabetes mellitus	5.82e-05	0.000689	CcSEcCtD
Hydralazine—Dyspepsia—Irbesartan—type 2 diabetes mellitus	5.79e-05	0.000687	CcSEcCtD
Hydralazine—Hypotension—Losartan—type 2 diabetes mellitus	5.79e-05	0.000686	CcSEcCtD
Hydralazine—Palpitations—Ramipril—type 2 diabetes mellitus	5.75e-05	0.000682	CcSEcCtD
Hydralazine—Feeling abnormal—Metformin—type 2 diabetes mellitus	5.75e-05	0.000681	CcSEcCtD
Hydralazine—Decreased appetite—Irbesartan—type 2 diabetes mellitus	5.72e-05	0.000678	CcSEcCtD
Hydralazine—Diarrhoea—Gliclazide—type 2 diabetes mellitus	5.7e-05	0.000676	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Irbesartan—type 2 diabetes mellitus	5.68e-05	0.000673	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Losartan—type 2 diabetes mellitus	5.64e-05	0.000669	CcSEcCtD
Hydralazine—Hypersensitivity—Valsartan—type 2 diabetes mellitus	5.64e-05	0.000669	CcSEcCtD
Hydralazine—Constipation—Irbesartan—type 2 diabetes mellitus	5.63e-05	0.000667	CcSEcCtD
Hydralazine—Hypersensitivity—Orlistat—type 2 diabetes mellitus	5.58e-05	0.000661	CcSEcCtD
Hydralazine—Paraesthesia—Losartan—type 2 diabetes mellitus	5.56e-05	0.000659	CcSEcCtD
Hydralazine—Urticaria—Metformin—type 2 diabetes mellitus	5.54e-05	0.000657	CcSEcCtD
Hydralazine—Myalgia—Ramipril—type 2 diabetes mellitus	5.54e-05	0.000657	CcSEcCtD
Hydralazine—Arthralgia—Ramipril—type 2 diabetes mellitus	5.54e-05	0.000657	CcSEcCtD
Hydralazine—Dyspnoea—Losartan—type 2 diabetes mellitus	5.52e-05	0.000654	CcSEcCtD
Hydralazine—Anxiety—Ramipril—type 2 diabetes mellitus	5.52e-05	0.000654	CcSEcCtD
Hydralazine—Nausea—Glyburide—type 2 diabetes mellitus	5.51e-05	0.000654	CcSEcCtD
Hydralazine—Dizziness—Gliclazide—type 2 diabetes mellitus	5.51e-05	0.000653	CcSEcCtD
Hydralazine—Discomfort—Ramipril—type 2 diabetes mellitus	5.47e-05	0.000649	CcSEcCtD
Hydralazine—Dyspepsia—Losartan—type 2 diabetes mellitus	5.45e-05	0.000646	CcSEcCtD
Hydralazine—Feeling abnormal—Irbesartan—type 2 diabetes mellitus	5.42e-05	0.000643	CcSEcCtD
Hydralazine—Pruritus—Valsartan—type 2 diabetes mellitus	5.42e-05	0.000642	CcSEcCtD
Hydralazine—Decreased appetite—Losartan—type 2 diabetes mellitus	5.38e-05	0.000638	CcSEcCtD
Hydralazine—Pruritus—Orlistat—type 2 diabetes mellitus	5.35e-05	0.000635	CcSEcCtD
Hydralazine—Oedema—Ramipril—type 2 diabetes mellitus	5.31e-05	0.000629	CcSEcCtD
Hydralazine—Vomiting—Gliclazide—type 2 diabetes mellitus	5.3e-05	0.000628	CcSEcCtD
Hydralazine—Constipation—Losartan—type 2 diabetes mellitus	5.3e-05	0.000628	CcSEcCtD
Hydralazine—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—type 2 diabetes mellitus	5.27e-05	0.00171	CbGpPWpGaD
Hydralazine—Rash—Gliclazide—type 2 diabetes mellitus	5.26e-05	0.000623	CcSEcCtD
Hydralazine—Dermatitis—Gliclazide—type 2 diabetes mellitus	5.25e-05	0.000622	CcSEcCtD
Hydralazine—Diarrhoea—Valsartan—type 2 diabetes mellitus	5.24e-05	0.000621	CcSEcCtD
Hydralazine—Urticaria—Irbesartan—type 2 diabetes mellitus	5.23e-05	0.00062	CcSEcCtD
Hydralazine—Headache—Gliclazide—type 2 diabetes mellitus	5.22e-05	0.000619	CcSEcCtD
Hydralazine—Body temperature increased—Irbesartan—type 2 diabetes mellitus	5.2e-05	0.000617	CcSEcCtD
Hydralazine—Thrombocytopenia—Ramipril—type 2 diabetes mellitus	5.2e-05	0.000616	CcSEcCtD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2E1—type 2 diabetes mellitus	5.19e-05	0.00168	CbGpPWpGaD
Hydralazine—Tachycardia—Ramipril—type 2 diabetes mellitus	5.18e-05	0.000614	CcSEcCtD
Hydralazine—Diarrhoea—Orlistat—type 2 diabetes mellitus	5.18e-05	0.000614	CcSEcCtD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP1A2—type 2 diabetes mellitus	5.13e-05	0.00166	CbGpPWpGaD
Hydralazine—Feeling abnormal—Losartan—type 2 diabetes mellitus	5.1e-05	0.000605	CcSEcCtD
Hydralazine—Dizziness—Valsartan—type 2 diabetes mellitus	5.06e-05	0.0006	CcSEcCtD
Hydralazine—Anorexia—Ramipril—type 2 diabetes mellitus	5.06e-05	0.0006	CcSEcCtD
Hydralazine—Dizziness—Orlistat—type 2 diabetes mellitus	5e-05	0.000593	CcSEcCtD
Hydralazine—Hypotension—Ramipril—type 2 diabetes mellitus	4.96e-05	0.000588	CcSEcCtD
Hydralazine—RYR2—Transmembrane transport of small molecules—ALB—type 2 diabetes mellitus	4.96e-05	0.00161	CbGpPWpGaD
Hydralazine—Nausea—Gliclazide—type 2 diabetes mellitus	4.95e-05	0.000587	CcSEcCtD
Hydralazine—Pruritus—Metformin—type 2 diabetes mellitus	4.93e-05	0.000585	CcSEcCtD
Hydralazine—Urticaria—Losartan—type 2 diabetes mellitus	4.92e-05	0.000583	CcSEcCtD
Hydralazine—Body temperature increased—Losartan—type 2 diabetes mellitus	4.9e-05	0.00058	CcSEcCtD
Hydralazine—Vomiting—Valsartan—type 2 diabetes mellitus	4.87e-05	0.000577	CcSEcCtD
Hydralazine—Hypersensitivity—Irbesartan—type 2 diabetes mellitus	4.85e-05	0.000575	CcSEcCtD
Hydralazine—Musculoskeletal discomfort—Ramipril—type 2 diabetes mellitus	4.84e-05	0.000574	CcSEcCtD
Hydralazine—Rash—Valsartan—type 2 diabetes mellitus	4.83e-05	0.000572	CcSEcCtD
Hydralazine—Dermatitis—Valsartan—type 2 diabetes mellitus	4.82e-05	0.000572	CcSEcCtD
Hydralazine—Vomiting—Orlistat—type 2 diabetes mellitus	4.81e-05	0.00057	CcSEcCtD
Hydralazine—Headache—Valsartan—type 2 diabetes mellitus	4.8e-05	0.000569	CcSEcCtD
Hydralazine—Diarrhoea—Metformin—type 2 diabetes mellitus	4.77e-05	0.000566	CcSEcCtD
Hydralazine—Rash—Orlistat—type 2 diabetes mellitus	4.77e-05	0.000566	CcSEcCtD
Hydralazine—Paraesthesia—Ramipril—type 2 diabetes mellitus	4.77e-05	0.000565	CcSEcCtD
Hydralazine—Dermatitis—Orlistat—type 2 diabetes mellitus	4.77e-05	0.000565	CcSEcCtD
Hydralazine—Headache—Orlistat—type 2 diabetes mellitus	4.74e-05	0.000562	CcSEcCtD
Hydralazine—Dyspnoea—Ramipril—type 2 diabetes mellitus	4.73e-05	0.000561	CcSEcCtD
Hydralazine—Dyspepsia—Ramipril—type 2 diabetes mellitus	4.67e-05	0.000554	CcSEcCtD
Hydralazine—Pruritus—Irbesartan—type 2 diabetes mellitus	4.66e-05	0.000552	CcSEcCtD
Hydralazine—Decreased appetite—Ramipril—type 2 diabetes mellitus	4.62e-05	0.000547	CcSEcCtD
Hydralazine—Dizziness—Metformin—type 2 diabetes mellitus	4.61e-05	0.000547	CcSEcCtD
Hydralazine—Gastrointestinal disorder—Ramipril—type 2 diabetes mellitus	4.58e-05	0.000543	CcSEcCtD
Hydralazine—Hypersensitivity—Losartan—type 2 diabetes mellitus	4.56e-05	0.000541	CcSEcCtD
Hydralazine—Nausea—Valsartan—type 2 diabetes mellitus	4.55e-05	0.000539	CcSEcCtD
Hydralazine—Constipation—Ramipril—type 2 diabetes mellitus	4.54e-05	0.000538	CcSEcCtD
Hydralazine—Diarrhoea—Irbesartan—type 2 diabetes mellitus	4.5e-05	0.000534	CcSEcCtD
Hydralazine—Nausea—Orlistat—type 2 diabetes mellitus	4.49e-05	0.000533	CcSEcCtD
Hydralazine—CYP3A4—Constitutive Androstane Receptor Pathway—PPARGC1A—type 2 diabetes mellitus	4.45e-05	0.00144	CbGpPWpGaD
Hydralazine—Vomiting—Metformin—type 2 diabetes mellitus	4.43e-05	0.000526	CcSEcCtD
Hydralazine—Rash—Metformin—type 2 diabetes mellitus	4.4e-05	0.000521	CcSEcCtD
Hydralazine—Dermatitis—Metformin—type 2 diabetes mellitus	4.39e-05	0.000521	CcSEcCtD
Hydralazine—Pruritus—Losartan—type 2 diabetes mellitus	4.38e-05	0.000519	CcSEcCtD
Hydralazine—Feeling abnormal—Ramipril—type 2 diabetes mellitus	4.38e-05	0.000519	CcSEcCtD
Hydralazine—Headache—Metformin—type 2 diabetes mellitus	4.37e-05	0.000518	CcSEcCtD
Hydralazine—Dizziness—Irbesartan—type 2 diabetes mellitus	4.35e-05	0.000516	CcSEcCtD
Hydralazine—Diarrhoea—Losartan—type 2 diabetes mellitus	4.24e-05	0.000502	CcSEcCtD
Hydralazine—Urticaria—Ramipril—type 2 diabetes mellitus	4.22e-05	0.0005	CcSEcCtD
Hydralazine—Body temperature increased—Ramipril—type 2 diabetes mellitus	4.2e-05	0.000498	CcSEcCtD
Hydralazine—Vomiting—Irbesartan—type 2 diabetes mellitus	4.18e-05	0.000496	CcSEcCtD
Hydralazine—Rash—Irbesartan—type 2 diabetes mellitus	4.15e-05	0.000492	CcSEcCtD
Hydralazine—Dermatitis—Irbesartan—type 2 diabetes mellitus	4.15e-05	0.000491	CcSEcCtD
Hydralazine—Nausea—Metformin—type 2 diabetes mellitus	4.14e-05	0.000491	CcSEcCtD
Hydralazine—Headache—Irbesartan—type 2 diabetes mellitus	4.12e-05	0.000489	CcSEcCtD
Hydralazine—Dizziness—Losartan—type 2 diabetes mellitus	4.1e-05	0.000485	CcSEcCtD
Hydralazine—CYP3A4—Tryptophan metabolism—CYP2E1—type 2 diabetes mellitus	4.08e-05	0.00132	CbGpPWpGaD
Hydralazine—CYP3A4—Tryptophan metabolism—CYP1A2—type 2 diabetes mellitus	4.03e-05	0.00131	CbGpPWpGaD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—type 2 diabetes mellitus	3.99e-05	0.00129	CbGpPWpGaD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—type 2 diabetes mellitus	3.94e-05	0.00128	CbGpPWpGaD
Hydralazine—Vomiting—Losartan—type 2 diabetes mellitus	3.94e-05	0.000467	CcSEcCtD
Hydralazine—Hypersensitivity—Ramipril—type 2 diabetes mellitus	3.91e-05	0.000464	CcSEcCtD
Hydralazine—Nausea—Irbesartan—type 2 diabetes mellitus	3.91e-05	0.000463	CcSEcCtD
Hydralazine—Rash—Losartan—type 2 diabetes mellitus	3.91e-05	0.000463	CcSEcCtD
Hydralazine—Dermatitis—Losartan—type 2 diabetes mellitus	3.9e-05	0.000462	CcSEcCtD
Hydralazine—Headache—Losartan—type 2 diabetes mellitus	3.88e-05	0.00046	CcSEcCtD
Hydralazine—Pruritus—Ramipril—type 2 diabetes mellitus	3.76e-05	0.000445	CcSEcCtD
Hydralazine—Nausea—Losartan—type 2 diabetes mellitus	3.68e-05	0.000436	CcSEcCtD
Hydralazine—Diarrhoea—Ramipril—type 2 diabetes mellitus	3.63e-05	0.000431	CcSEcCtD
Hydralazine—Dizziness—Ramipril—type 2 diabetes mellitus	3.51e-05	0.000416	CcSEcCtD
Hydralazine—CYP3A4—Biological oxidations—MAT1A—type 2 diabetes mellitus	3.5e-05	0.00113	CbGpPWpGaD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—type 2 diabetes mellitus	3.41e-05	0.00111	CbGpPWpGaD
Hydralazine—Vomiting—Ramipril—type 2 diabetes mellitus	3.38e-05	0.0004	CcSEcCtD
Hydralazine—Rash—Ramipril—type 2 diabetes mellitus	3.35e-05	0.000397	CcSEcCtD
Hydralazine—Dermatitis—Ramipril—type 2 diabetes mellitus	3.35e-05	0.000397	CcSEcCtD
Hydralazine—Headache—Ramipril—type 2 diabetes mellitus	3.33e-05	0.000394	CcSEcCtD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—type 2 diabetes mellitus	3.3e-05	0.00107	CbGpPWpGaD
Hydralazine—CYP3A4—Tryptophan metabolism—CAT—type 2 diabetes mellitus	3.27e-05	0.00106	CbGpPWpGaD
Hydralazine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A2—type 2 diabetes mellitus	3.26e-05	0.00106	CbGpPWpGaD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—type 2 diabetes mellitus	3.25e-05	0.00105	CbGpPWpGaD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—type 2 diabetes mellitus	3.24e-05	0.00105	CbGpPWpGaD
Hydralazine—CYP3A4—Oxidation by Cytochrome P450—CYP1A2—type 2 diabetes mellitus	3.22e-05	0.00104	CbGpPWpGaD
Hydralazine—Nausea—Ramipril—type 2 diabetes mellitus	3.15e-05	0.000374	CcSEcCtD
Hydralazine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—type 2 diabetes mellitus	2.82e-05	0.000914	CbGpPWpGaD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—type 2 diabetes mellitus	2.67e-05	0.000866	CbGpPWpGaD
Hydralazine—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—type 2 diabetes mellitus	2.64e-05	0.000856	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—MTR—type 2 diabetes mellitus	1.78e-05	0.000575	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—CYP11A1—type 2 diabetes mellitus	1.72e-05	0.000557	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—CYP11A1—type 2 diabetes mellitus	1.7e-05	0.00055	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—CYP2E1—type 2 diabetes mellitus	1.42e-05	0.00046	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—CYP1A2—type 2 diabetes mellitus	1.4e-05	0.000455	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—CYP2E1—type 2 diabetes mellitus	1.4e-05	0.000454	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—CYP1A2—type 2 diabetes mellitus	1.38e-05	0.000449	CbGpPWpGaD
Hydralazine—CYP3A4—Biological oxidations—GSTM1—type 2 diabetes mellitus	1.08e-05	0.000349	CbGpPWpGaD
Hydralazine—CYP3A4—Metapathway biotransformation—GSTM1—type 2 diabetes mellitus	1.06e-05	0.000344	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—BHMT—type 2 diabetes mellitus	8.21e-06	0.000266	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PTGDS—type 2 diabetes mellitus	7.17e-06	0.000232	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—AANAT—type 2 diabetes mellitus	7.17e-06	0.000232	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CDO1—type 2 diabetes mellitus	6.8e-06	0.00022	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GPD2—type 2 diabetes mellitus	6.8e-06	0.00022	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—AK1—type 2 diabetes mellitus	6.49e-06	0.00021	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SLC5A4—type 2 diabetes mellitus	5.99e-06	0.000194	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—MAT1A—type 2 diabetes mellitus	5.99e-06	0.000194	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—G6PC—type 2 diabetes mellitus	5.78e-06	0.000187	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HBA2—type 2 diabetes mellitus	5.78e-06	0.000187	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPP1R3C—type 2 diabetes mellitus	5.78e-06	0.000187	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ENPP1—type 2 diabetes mellitus	5.78e-06	0.000187	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ND1—type 2 diabetes mellitus	5.78e-06	0.000187	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GCGR—type 2 diabetes mellitus	5.6e-06	0.000181	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYTB—type 2 diabetes mellitus	5.29e-06	0.000171	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—OXCT1—type 2 diabetes mellitus	5.29e-06	0.000171	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SRD5A1—type 2 diabetes mellitus	5.15e-06	0.000167	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ACACA—type 2 diabetes mellitus	4.92e-06	0.000159	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—STAR—type 2 diabetes mellitus	4.92e-06	0.000159	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HSD17B3—type 2 diabetes mellitus	4.92e-06	0.000159	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ABCC8—type 2 diabetes mellitus	4.71e-06	0.000153	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CBS—type 2 diabetes mellitus	4.71e-06	0.000153	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SLC5A2—type 2 diabetes mellitus	4.54e-06	0.000147	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—COX2—type 2 diabetes mellitus	4.54e-06	0.000147	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—NCOA6—type 2 diabetes mellitus	4.46e-06	0.000144	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—UCP2—type 2 diabetes mellitus	4.38e-06	0.000142	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HSD11B1—type 2 diabetes mellitus	4.38e-06	0.000142	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—UCP3—type 2 diabetes mellitus	4.38e-06	0.000142	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PCK1—type 2 diabetes mellitus	4.12e-06	0.000133	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HK1—type 2 diabetes mellitus	3.86e-06	0.000125	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GCKR—type 2 diabetes mellitus	3.73e-06	0.000121	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—LPA—type 2 diabetes mellitus	3.73e-06	0.000121	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—KCNJ11—type 2 diabetes mellitus	3.73e-06	0.000121	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HSD3B2—type 2 diabetes mellitus	3.73e-06	0.000121	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ALDOB—type 2 diabetes mellitus	3.57e-06	0.000116	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GLP1R—type 2 diabetes mellitus	3.32e-06	0.000108	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SLC2A2—type 2 diabetes mellitus	3.1e-06	0.0001	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—MTR—type 2 diabetes mellitus	3.04e-06	9.84e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CPT1A—type 2 diabetes mellitus	3.04e-06	9.84e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—NAMPT—type 2 diabetes mellitus	2.98e-06	9.65e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HBA1—type 2 diabetes mellitus	2.96e-06	9.59e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—LIPC—type 2 diabetes mellitus	2.96e-06	9.59e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GCK—type 2 diabetes mellitus	2.96e-06	9.59e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYP11A1—type 2 diabetes mellitus	2.94e-06	9.53e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SLC9A1—type 2 diabetes mellitus	2.89e-06	9.36e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CETP—type 2 diabetes mellitus	2.86e-06	9.25e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PSMD6—type 2 diabetes mellitus	2.65e-06	8.6e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SNAP25—type 2 diabetes mellitus	2.65e-06	8.6e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SREBF1—type 2 diabetes mellitus	2.65e-06	8.6e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CTGF—type 2 diabetes mellitus	2.61e-06	8.44e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HMGCR—type 2 diabetes mellitus	2.58e-06	8.37e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ADRA2A—type 2 diabetes mellitus	2.53e-06	8.19e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYP2E1—type 2 diabetes mellitus	2.43e-06	7.87e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SLC2A1—type 2 diabetes mellitus	2.4e-06	7.78e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CYP1A2—type 2 diabetes mellitus	2.4e-06	7.78e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—SLC2A4—type 2 diabetes mellitus	2.3e-06	7.46e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GCG—type 2 diabetes mellitus	2.3e-06	7.46e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GNB3—type 2 diabetes mellitus	1.98e-06	6.43e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPARGC1A—type 2 diabetes mellitus	1.98e-06	6.43e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—HMOX1—type 2 diabetes mellitus	1.97e-06	6.4e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CAT—type 2 diabetes mellitus	1.95e-06	6.31e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOB—type 2 diabetes mellitus	1.89e-06	6.13e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GSTM1—type 2 diabetes mellitus	1.84e-06	5.96e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—LPL—type 2 diabetes mellitus	1.81e-06	5.85e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ADCY5—type 2 diabetes mellitus	1.77e-06	5.73e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—GPX1—type 2 diabetes mellitus	1.76e-06	5.71e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CD36—type 2 diabetes mellitus	1.72e-06	5.56e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPP2CA—type 2 diabetes mellitus	1.69e-06	5.49e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—MTHFR—type 2 diabetes mellitus	1.63e-06	5.27e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPARA—type 2 diabetes mellitus	1.6e-06	5.17e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—AGT—type 2 diabetes mellitus	1.55e-06	5.01e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—CALM1—type 2 diabetes mellitus	1.52e-06	4.92e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOE—type 2 diabetes mellitus	1.51e-06	4.91e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—APOA1—type 2 diabetes mellitus	1.5e-06	4.85e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PPARG—type 2 diabetes mellitus	1.32e-06	4.27e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—INS—type 2 diabetes mellitus	1.29e-06	4.19e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—ALB—type 2 diabetes mellitus	1.19e-06	3.84e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PIK3R1—type 2 diabetes mellitus	1.13e-06	3.67e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—NOS3—type 2 diabetes mellitus	1.13e-06	3.67e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—PTGS2—type 2 diabetes mellitus	1.04e-06	3.36e-05	CbGpPWpGaD
Hydralazine—CYP3A4—Metabolism—AKT1—type 2 diabetes mellitus	5.21e-07	1.69e-05	CbGpPWpGaD
